Xylazine Warning for Vermont’s Veterinarians From VT Dept. of Health

The Health Department recently published a data brief on the emerging trend of xylazine contributing to fatal opioid overdoses based on a CDC Morbidity and Mortality Weekly Report. Vermont’s data brief can be found here: https://www.healthvermont.gov/sites/default/files/documents/pdf/ADAP - XylazineBrief.pdf

  • Law enforcement believes that xylazine may be added as a toxic adulterant in illicit opioids in the US, and it is being added before those opioids arrive in Vermont.

  • In the past, trends like this originate in larger urban centers in the Northeast and Mid- Atlantic before they are detected in Vermont; this trend is currently being seen in these urban areas.

  • We request that Vermont’s veterinarians closely monitor their supplies of xylazine for potential diversion, including taking care to not dispense single doses of xylazine for subsequent and unsupervised use.

  • If you suspect drug diversion, please follow your usual notification pathway, which may include law enforcement or the Vermont Office of Professional Regulation.

    Please direct any questions about the data brief to the Health Department’s Substance Misuse Prevention Manager, Nicole Rau.

Save the Dates and More!

The VVMA Winter Meeting 2022 will be in-person at the DoubleTree by Hilton Hotel in South Burlington, VT,  February 5 and 6.  Mark your calendars and save the dates  Details to follow.


Special Offer: Now through December 31, 2021, ALL employers can receive 30% off their next 30-Day Nationwide Job Posting on the Veterinary Career Network by using promo code 30OFF during checkout!


Thank you to our Summer Meeting Platinum and Gold Sponsors!

Zoetis logo cropped

Vaxxinova Logo